Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    23361625 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Small Volume Plasma Exchange (SVPE) for Guillain-Barré Syndrome (GBS) Patients
Condition: Guillain-Barré Syndrome
Intervention: Procedure: Small Volume Plasma Exchange
2 Unknown  Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia
Conditions: Septic Shock;   Nonchemotherapy Drug-induced Neutropenia;   Neutropenia After Chemotherapy in Oncohematological Patients;   Neutropenia in Patients With Aplastic Anemia
Interventions: Genetic: Mesenchymal stromal cells;   Drug: Standard therapy of septic shock
3 Recruiting A Randomized Controlled Study of Enteral Nutrition in Septic Shock
Condition: Septic Shock
Intervention: Other: Enteral nutrition
4 Completed Steroid Use in Pediatric Fluid and Vasoactive Infusion Dependent Shock - Pilot Study
Condition: Shock
Interventions: Drug: Hydrocortisone;   Other: Placebo
5 Not yet recruiting Carotid VTI as a Measure of Intravascular Volume Status During Lower Body Negative Pressure Simulation
Conditions: Hemodynamics;   Ultrasonography
Intervention: Other: Point of Care Ultrasound
6 Recruiting Physiologic Effects of Steroids in Cardiac Arrest
Condition: Inhospital Cardiac Arrest
Interventions: Drug: Methylprednisolone; hydrocortisone;   Drug: Saline Placebo
7 Not yet recruiting Ulinastatin Treatment in Adult Patients With Severe Sepsis and Septic Shock in China
Conditions: Severe Sepsis;   Septic Shock
Interventions: Drug: ulinastatin;   Drug: Placebo
8 Recruiting Evaluation of the Heparin Binding Protein Levels in Sepsis
Conditions: Sepsis;   Infection;   Septic Shock
Intervention: Other: HBP lab test
9 Completed Individual Patient Data-based Re-analysis of Synthesized Prior Randomized Clinical Trial Data Assessing the Effect of Steroids on Post-resuscitation Infections
Conditions: Infections;   Cardiac Arrest
Intervention: Drug: Stress-dose hydrocortisone

Study has passed its completion date and status has not been verified in more than two years.